High circulating IL-6 level in Graves' ophthalmopathy

Area of Science:

• Immunology
• Endocrinology
• Ophthalmology

Background:

• Interleukin-6 (IL-6) is a key cytokine regulating immune and inflammatory responses.
• Thyrocytes can produce IL-6, suggesting its potential role in thyroid-related conditions.

Purpose of the Study:

• To investigate serum IL-6 levels in Graves' disease patients with and without ophthalmopathy.
• To correlate IL-6 levels with inflammatory eye signs, thyroid function, and treatment modalities.

Main Methods:

• Serum IL-6 levels were measured in patients with Graves' disease (N=47) and controls (N=29).
• Levels were compared between groups with and without ophthalmopathy, considering disease duration and inflammatory signs.
• The influence of thyroid function and treatments (radioiodine, medical) was assessed.

Main Results:

• Serum IL-6 levels were significantly elevated in patients with ophthalmopathy (440 pg/ml) compared to those without (81.6 pg/ml).
• Elevated IL-6 correlated with longer disease duration (>1 year) and inflammatory eye signs in Graves' hyperthyroidism.
• Thyroid function and thyroiditis presence did not impact IL-6 levels; treatments showed no significant decrease.

Conclusions:

• IL-6 cytokine is a significant factor in the inflammatory processes of Graves' ophthalmopathy.
• Elevated IL-6 may serve as a biomarker for active inflammation in Graves' ophthalmopathy.